Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EZZ has a commercial portfolio of science-backed nutraceuticals and wellness products with a focus on genomics-driven innovation. The company has received FDA approval for nine of its food-category products for the US market in June 2025. It continues to expand internationally through new distribution agreements and product launches targeting key areas such as genetic longevity, HPV, helicobacter pylori management, weight control, and children’s nutrition.[10]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EZZ Life Science Holdings Limited.